Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease

Medicine & Life Sciences

1. Steroids 100%
2. Immunoglobulins 91%
3. T-Lymphocytes 75%
4. Graft vs Host Disease 56%
5. Myeloid Cells 29%
6. T-Cell Antigen Receptor 28%
7. Monocytes 17%
8. Calcineurin Inhibitors 17%
9. T-Cell Leukemia 17%
10. Hematopoietic Stem Cell Transplantation 16%
11. Anti-Inflammatory Agents 15%
12. Allogeneic Cells 15%
13. Transplants 13%
14. Monoclonal Antibodies 12%
15. Immune System 12%
16. Transplantation 11%
17. Antibodies 11%
18. Tissue Donors 11%
19. Macrophages 11%
20. Public Health 10%
21. Antigens 9%
22. Cytokines 8%
23. Chemotaxis 7%
24. Therapeutics 5%
25. Signal Transduction 5%
26. Survival Rate 5%